Condition

AIDS-Related Primary Effusion Lymphoma

ClinicalTrials.gov condition label

Clinical trials2

Recruiting0

Common interventions11

Lead sponsors shown2

Clinical trials

2 shown

Gene Therapy and Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin LymphomaNCT02337985 · 2015-11-20

ACTIVE_NOT_RECRUITING

Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell LymphomasNCT01193842 · 2010-10-06

COMPLETED

Common interventions

CyclophosphamideDRUG2Doxorubicin HydrochlorideDRUG2EtoposideDRUG2PrednisoneDRUG2RituximabBIOLOGICAL2Vincristine SulfateDRUG2FilgrastimBIOLOGICAL1Laboratory Biomarker AnalysisOTHER1Lentivirus Vector rHIV7-shI-TAR-CCR5RZ-transduced Hematopoietic Stem/Progenitor CellsBIOLOGICAL1Pharmacological StudyOTHER1VorinostatDRUG1

Leading sponsors

City of Hope Medical Center1National Cancer Institute (NCI)1

Trial status mix

ACTIVE_NOT_RECRUITING1

COMPLETED1

Phase mix

PHASE12

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.